Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Examine the ability of thymopentin (Timunox) to:
Reduce the amount and/or frequency of virus isolation. Stimulate the immune system and alter the clinical findings in patients infected with HIV who do not yet have AIDS.
|Study Design:||Masking: Double-Blind
Primary Purpose: Treatment
|Official Title:||Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|